| Patents for A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316) |
|---|
| 01/06/2005 | CA2531058A1 Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus |
| 01/06/2005 | CA2527052A1 Angiogenic agents from plant extracts, gallic acid, and derivatives |
| 01/05/2005 | EP1493431A2 Use of an extract of bauhinia for the preparation of pharmaceutical and cosmetic compositions |
| 01/05/2005 | EP1492551A2 Ophthalmic, pharmaceutical and other healthcare preparations with naturally occuring plant compounds, extracts and derivatives |
| 01/05/2005 | EP1492496A2 Skincare compositions comprising anti-oxidant agents |
| 01/05/2005 | EP1492414A2 Method and dietary composition for improving fat digestibility |
| 01/05/2005 | EP1411909B1 Pharmaceutical composition comprising (-)-secoisolariciresinol |
| 01/05/2005 | EP1397138B1 ACTIVE INGREDIENT COMBINATION (e.g. galanthamine or desoxypeganine with acamprosate or Memantine) FOR TREATING A DEPENDENCE ON ADDICTIVE SUBSTANCES OR NARCOTICS |
| 01/05/2005 | EP1261358B1 Use of a composition comprising morinda citrifolia for the treatment of tinnitus |
| 01/05/2005 | EP0996451B1 Triterpene saponin analogs having adjuvant and immunostimulatory activity |
| 01/05/2005 | DE20220937U1 Herbal tea for treatment of diabetes, comprises seven components, restores metabolism, normalizes body weight and improves function of the intestines |
| 01/05/2005 | DE102004028805A1 Mittel zur Förderung der Collagenbildung Means to promote collagen formation |
| 01/05/2005 | CN1561391A Recombinant bacterial phytases and uses thereof |
| 01/05/2005 | CN1561221A Novel medicinal herbal composition for treating liver diseases and HIV |
| 01/05/2005 | CN1561218A Enteral compositions for the prevention and/or treatment of sepsis |
| 01/05/2005 | CN1561206A Compositions having effects of preventing or ameliorating conditions or diseases caused by brain hypofunction |
| 01/05/2005 | CN1561197A Method for producing biologically active products |
| 01/05/2005 | CN1561164A 抗微生物剂 Antimicrobial agent |
| 01/04/2005 | US6838481 Blocking melanin biosynthesis; side effect reduction |
| 01/04/2005 | US6838431 Nutritional intervention composition containing a source of proteinase inhibitor extending post meal satiety |
| 01/04/2005 | US6838103 Deterioration preventive agent for milk-containing foods |
| 01/04/2005 | US6838096 Black soybean polysaccharides |
| 01/04/2005 | US6838092 Effervescent compositions containing dried fruit juices |
| 01/04/2005 | US6838091 Lipid-regulating agent, particularly fenofibrate, dissolved in a monoglyceride. |
| 12/30/2004 | US20040266888 Composition for treatment of infections of humans and animals |
| 12/30/2004 | US20040266874 Contains, as active ingredient, arachidonic acid and/or a compound having arachidonic acid as a constituent fatty acid and, particularly, an alcohol ester of arachidonic acid or a triglyceride, phospholipid or glycolipid in which all or a portion of constituent fatty acids are arachidonic acid |
| 12/30/2004 | US20040266726 yeast-derived ingredient having beta 1,3/1.6 glucan structure (IMMUTOL) or Norwegian Beta Glucan (TM); natural killer cell activating capabilities and tumor angiogenesis inhibiting capability by oral administration |
| 12/30/2004 | US20040265452 Application under the patent cooperation treaty |
| 12/30/2004 | US20040265427 Novel non-antibiotic strategy against ogip infections based on an activated cereal product or ferric quinate |
| 12/30/2004 | US20040265426 Process for producing miso |
| 12/30/2004 | US20040265404 plant extracts containig flavonoids such as gallic acid, epigallocatechin gallate or epicatechin gallate used as drugs, nutraceuticals or in foods |
| 12/30/2004 | US20040265403 nutraceuticals comprising plant extracts used as neuroprotectants and cognition activators |
| 12/30/2004 | US20040265402 Pharmaceutical composition and method for making the same |
| 12/30/2004 | US20040265401 Chemical composition for aiding the absorption, binding and elimination of undigested fat |
| 12/30/2004 | US20040265400 Compositions for enhancing sexual responsiveness |
| 12/30/2004 | US20040265399 plant extracts used for prevention or treatment of lesions caused by estrogen deficiency |
| 12/30/2004 | US20040265398 administering dietetics comprising plant extracts and optionally stimulants and/or glucosamine as anorexigenic agents |
| 12/30/2004 | US20040265397 mixtures of plant extracts used for prophylaxis of kidney or urogenital disorders |
| 12/30/2004 | US20040265344 Laxatives, antiinflammatory agents, antiallergens, and wound healing agents; treatment of hemorrhoids, bacterial infections of the anus, and constipation; side effect reduction |
| 12/30/2004 | US20040265343 Alkali salts of fatty acids, plant extracts, and glycerine; drugs and cosmetics; activate gelling agents; substantivity |
| 12/30/2004 | US20040265335 Herbal composition and method of treating HIV infection |
| 12/30/2004 | US20040265247 Mouth rinse composition |
| 12/30/2004 | DE20318975U1 Pharmaceutical composition for treating dental or gum diseases contains vervain and/or rib-wort or materials containing them or their extracts |
| 12/30/2004 | DE202004017113U1 Momordica charantia-Zimt-Zubereitung Momordica charantia cinnamon Preparation |
| 12/30/2004 | DE202004017112U1 Herbal composition especially for use in diet plans for diabetes mellitus contains Momordica charantia (bitter melon) and other plant parts |
| 12/29/2004 | WO2004112904A1 Medicament comprising plant material from mascagnia eggersiana for treating type 2 diabetes mellitus |
| 12/29/2004 | WO2004112819A1 Compositions and methods of treatment comprising plant extracts |
| 12/29/2004 | WO2004112818A1 Compositions containing butterbur-extract |
| 12/29/2004 | WO2004112817A1 Extract from plant of japanese parsley family and process for producing the same |
| 12/29/2004 | WO2004112816A1 Fermentation product and process for producing the same |
| 12/29/2004 | WO2004112815A1 Melanogenesis promoter and melanogenesis promoter composition |
| 12/29/2004 | WO2004112812A1 Use of parts or extract of amarathus blitoides |
| 12/29/2004 | WO2004112811A1 Eye-rinse solution made of grape juice |
| 12/29/2004 | WO2004112809A1 Composition for lowering serum uric acid level |
| 12/29/2004 | WO2004112802A1 Composition comprising soluble glucan oligomer from saccharomyces cerevisiae is2 inhibiting the swine influenza (siv) and transmissible gastroenteritis coronavirus (tgev) |
| 12/29/2004 | WO2004112775A1 Composition for preventing urinary system infections |
| 12/29/2004 | WO2004112773A1 Pharmaceutical compositions used for immune disease treatment and improvement |
| 12/29/2004 | WO2004112483A1 Nutraceutical for the prevention and treatment of cancers and diseases affecting the liver |
| 12/29/2004 | WO2004089357A3 Anti-fungal formulation of triterpene and essential oil |
| 12/29/2004 | WO2004087181A8 ACTIVE INGREDIENT COMBINATIONS OF PLANT OILS CONTAINING ω3-FATTY ACIDS AND PLANT EXTRACTS CONTAINING POLYPHENOLS AND THE USE THEREOF |
| 12/29/2004 | WO2004078157A3 Regulation of mammalian hair growth |
| 12/29/2004 | WO2004048419A9 Method of classifying, purifying and using fenugreek seeds |
| 12/29/2004 | EP1491216A1 Drugs comprising protein forming hollow nanoparticles and therapeutic substance to be transferred into cells fused therewith |
| 12/29/2004 | EP1491204A1 Process for producing fat composition containing hydrophobic components of glycyrrhiza |
| 12/29/2004 | EP1491203A1 Compositions for treating and/or preventing pollenosis |
| 12/29/2004 | EP1491202A1 Nail restructuring compositions for topical application |
| 12/29/2004 | EP1491192A1 Biological activity-promoting compositions containing soybean germ-origin isoflavone aglycon |
| 12/29/2004 | EP1491183A2 Use of a plant extract of the Rosaceae family |
| 12/29/2004 | EP1490081A1 Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia |
| 12/29/2004 | EP1490080A1 A process for the extraction of anthocyanins from black rice and composition thereof |
| 12/29/2004 | EP1490079A1 A composition for treating gastric ulcer and a process for preparing the same |
| 12/29/2004 | EP1490078A1 Hepatocurative effect of emblica officinalis on hepatotoxicity related to cytochrome p-450 |
| 12/29/2004 | EP1490077A1 A photoprotective orally administrable composition for skin |
| 12/29/2004 | EP1490040A2 Anti-inflammatory formulations |
| 12/29/2004 | EP1489924A2 Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof |
| 12/29/2004 | EP1368046B1 Pharmaceutical formulation and the use thereof for preparing a medicament for the treatment of cardiovascular diseases |
| 12/29/2004 | EP1287827B1 Immunopotentiator |
| 12/29/2004 | CN1558769A Compositions comprising organic extracts of Geum Japonicum thunb var. and the use thereof |
| 12/29/2004 | CN1558768A A pharmaceutical composition made from Chinese traditional medicine and preparation method thereof |
| 12/29/2004 | CN1558767A A pharmaceutical composition made from Chinese traditional medicine for treating snuffle, headache and preparation method thereof |
| 12/29/2004 | CN1558724A Herbal nutraceutical formulation for females/expectant mothers and its process of preparation |
| 12/29/2004 | CN1557388A Poisonous element content decreasing Kawa extracts and its composition and preparing method |
| 12/29/2004 | CN1557167A Traditional Chinese medicine compound for environmental sanitation and its preparation method |
| 12/29/2004 | CN1181826C Lipid-based immune regulator composition |
| 12/29/2004 | CN1181742C Blood pressure and blood fat lowering herbal food |
| 12/29/2004 | CA2530036A1 Medicament, in particular for the treatment of diabetes mellitus type 2 |
| 12/29/2004 | CA2529288A1 Composition for lowering serum uric acid level |
| 12/29/2004 | CA2528288A1 Nutraceutical for the prevention and treatment of cancers and diseases affecting the liver |
| 12/28/2004 | US6835709 Uses an anisaldehyde as the stimulative agent. |
| 12/28/2004 | US6835401 Method of treating diseases caused by over-production of free-radicals |
| 12/23/2004 | WO2004110468A1 Transdermal compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms |
| 12/23/2004 | WO2004110467A1 Natural extract with hypoglycaemic activity and method of obtaining same |
| 12/23/2004 | WO2004110463A1 Compositions for prevention and treatment of cold and influenza-like symptoms comprising chelated zinc |
| 12/23/2004 | WO2004110428A1 Anti-inflammatory analgesic adhesive patch |
| 12/23/2004 | WO2004110413A1 A composition for an enteric coating of natural product containing lectin |
| 12/23/2004 | WO2004110401A2 Inhalation antiviral patch |
| 12/23/2004 | WO2004110383A2 Pharmaceutical composition and method for alleviating side effects of estrogen replacement therapy |
| 12/23/2004 | WO2004110174A1 Composition and foods for lowering glycemic index |
| 12/23/2004 | WO2004110153A1 Agents against microorganisms, containing patchouli oil, patchouli alcohol and/or the derivatives thereof |
| 12/23/2004 | WO2004089891A8 Process for isolating antioxidants from plant waste material, and their use as foodstuff supplement |